gadolinium has been researched along with Plasmacytoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Nayer, P; Garbar, C; Lecouvet, FE; Maldague, BE; Malghem, J; Noël, H; Vande Berg, BC | 1 |
| Cordes, M; Felix, R; Hosten, N; Huhn, D; Kirsch, A; Neumann, K; Oertel, J; Sander, B; Schörner, W; Schubeus, P | 1 |
2 other study(ies) available for gadolinium and Plasmacytoma
| Article | Year |
|---|---|
Treated plasma cell lesions of bone with MRI signs of response to treatment: unexpected pathological findings.
Topics: Adult; Bone and Bones; Bone Neoplasms; Cell Survival; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Necrosis; Plasma Cells; Plasmacytoma | 1998 |
[Magnetic resonance tomographic screening studies of the bone marrow with gradient-echo sequences. II. Gadolinium-DTPA-supported studies of plasmocytoma patients].
Topics: Bone Marrow; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasm Staging; Organometallic Compounds; Pentetic Acid; Plasmacytoma; Tomography, X-Ray Computed | 1992 |